• Psoriasis
  • Symptoms & Diagnosis
  • Types
  • Locations
  • Triggers
  • Psoriasis Treatments

  

  • Accessing Health Care
  • Resources and Tools
• Psoriatic Arthritis
  • Symptoms & Diagnosis
  • Types
  • Treatments

  

  • Accessing Health Care
  • Resources and Tools
• Research
  • Research Priorities

  • NPF-Funded Research
  • Victor Henschel BioBank
  • Science of Psoriatic Diseases

  • For Researchers

  Location:	Any Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachussetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming
  Condition:	Psoriasis Psoriatic Arthritis

• Advocacy
  • Policy Priorities
  • Take Action
  • Advocacy News and Events

  • For Policy Makers
• In Your Area
  

  • Events and Programs
  • Calendar of Events
  • Walk to Cure Psoriasis
• Get Involved
  • Walk to Cure Psoriasis
  • Donate
  • Advocate
  • Volunteer
  • Special Events
  • Calendar of Events
• Donate
  

  • Ways to Give
  • Become a Member
  • Support Research
  • Remember NPF in Your Will
  • Fundraising Events
  • Give Stock
  • Tribute and Memorial Gifts
  • Become a Professional Member

Drugs in Development

Research into psoriasis and psoriatic arthritis treatments has come a long way since ancient times, when Hippocrates, the Greek "Father of Medicine" recommended arsenic to treat psoriasis or when 19th-century physicians prescribed treatments that included such ingredients as nitrate, sulfur and mercury.

Thanks to diligent scientific research, today's treatments are providing a wide range of safe and effective options for people with psoriasis and psoriatic arthritis. And the search is continuing for safer and even more effective treatments.

The National Psoriasis Foundation tracks the movement of drugs for psoriasis and psoriatic arthritis from preliminary studies through the three phases of clinical trials as required by the U.S. Food and Drug Administration. This information is compiled, along with that from other sources, and entered into our own drug research pipeline. We use this tool to monitor the progress of psoriasis and psoriatic arthritis treatments from early stages of development to when they become available to patients.

Drug Approval Process

Learn more about what it takes to bring a new drug from the lab to your medicine cabinet.

Psoriasis and Psoriatic Arthritis Drugs in the Research Pipeline

NPF's research pipeline features treatments currently being tested for psoriasis and psoriatic arthritis.

Clinical Trials

Information about the clinical trial process, including how you can participate in a clincial trial.